Thymic peptide hormones: basic properties and clinical applications in cancer

Area of Science:

• Immunology
• Endocrinology
• Biochemistry

Background:

• Thymic factors, including partially purified preparations and synthetic peptides, have been investigated for their immunomodulatory effects.
• The classification of thymic peptides as hormones requires further clarification based on their biochemical and biological properties.

Purpose of the Study:

• To critically review the nomenclature, biochemistry, biological properties, and clinical trial data of all reported thymic preparations.
• To determine which thymic peptides should be classified as true hormones.
• To summarize and contrast the comparative biochemistry and biological activity of available thymic factors.

Main Methods:

• Comprehensive literature review of published and ongoing clinical trials.
• Comparative analysis of biochemical and biological data for various thymic factors.
• In vitro studies examining thymic factor effects on lymphocytes from diverse patient groups.

Main Results:

• Detailed review of thymosin fraction 5, thymostimulin, thymosin alpha 1, and thymulin.
• Comparative summary of animal studies on thymic factor biochemistry and activity.
• Analysis of in vitro effects on lymphocytes from immunodeficient, autoimmune, and cancer patients.

Conclusions:

• Thymic factors exhibit diverse biological activities and varying potential as therapeutic agents.
• Further research is needed to definitively classify certain thymic peptides as hormones.
• Clinical trial data suggests potential applications in cancer treatment and immune disorders.